ArticleInternational journal of clinical and experimental pathology2019

CREPT is a novel predictor of the response to adjuvant therapy or concurrent chemoradiotherapy in esophageal squamous cell carcinoma.

Shuaixia Yu et al.PubMed ↗Full text ↗

No numbers read from the abstract.